JAK Inhibitors in RA: Applying Evidence-Based Strategies in Clinical Decision-making

Download All
Hear from renowned rheumatology experts on the latest insights about the application of efficacy and safety data for JAK inhibitors in RA management.
Vivian P. Bykerk, MD, FRCPC
person default
Vibeke Strand, MD, MACR, FACP

Downloadable Slideset

Hear from the experts as they highlight the latest clinical trial and real-world evidence regarding JAK inhibitor efficacy and safety to help contextualize risks and apply practical mitigation strategies to comprehensive care plans.

Vivian P. Bykerk, MD, FRCPC person default Vibeke Strand, MD, MACR, FACP Released: November 14, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by an educational grant from
Lilly

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings